secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001159036-26-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme amends bylaws to allow director removal with or without cause by majority vote
--------------------------------------------------------------------------------

- Board amended Section 2.5 to permit removal of directors at any time, with or without cause, by majority of shares entitled to vote.
- Section 1.12 amended to clarify stockholder actions cannot be taken without a meeting, consistent with the Certificate of Incorporation.
- Amendments adopted by Board on April 22, 2026; full text filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000051/0001159036-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000051/halo-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001159036-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer